Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Lintker KB et al. | A comparison of the packing behavior of egg phosphatidylcholine with cholesterol and biogenically related sterols in Langmuir monolayer films. | 2009 | Chem. Phys. Lipids | pmid:19524563 |
Benesch MG et al. | A DSC and FTIR spectroscopic study of the effects of the epimeric 4-cholesten-3-ols and 4-cholesten-3-one on the thermotropic phase behaviour and organization of dipalmitoylphosphatidylcholine bilayer membranes: comparison with their 5-cholesten analogues. | 2014 | Chem. Phys. Lipids | pmid:24296232 |
Miller J and Tarter TH | Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. | 2009 | Clin Interv Aging | pmid:19554096 |
Wheeler RE | Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution). | 2007 | Clin Interv Aging | pmid:18044088 |
van Gorselen EO et al. | Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia. | 2010 | Clin Res Cardiol | pmid:20593189 |
Kotłowska A et al. | The urinary steroid profile in patients diagnosed with adrenal incidentaloma. | 2009 | Clin. Biochem. | pmid:19297679 |
Donato LJ et al. | Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. | 2018 | Clin. Biochem. | pmid:29051033 |
Taplin ME et al. | Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. | 2009 | Clin. Cancer Res. | pmid:19887483 |
Mohler JL et al. | Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone. | 2011 | Clin. Cancer Res. | pmid:21705451 |
Dixon J et al. | Prolonged human chorionic gonadotrophin stimulation as a tool for investigating and managing undescended testes. | 2007 | Clin. Endocrinol. (Oxf) | pmid:17645564 |